BACK TO TOP
KSE100
167,563.68
1280.13
(0.77%)
KSE100PR
52,640.28
402.15
(0.77%)
ALLSHR
101,507.20
764.14
(0.76%)
KSE30
50,883.91
402.06
(0.80%)
KMI30
240,347.64
2255.60
(0.95%)
BKTI
45,348.93
267.46
(0.59%)
OGTI
33,491.07
410.41
(1.24%)
KMIALLSHR
66,162.28
544.82
(0.83%)
PSXDIV20
73,519.40
464.35
(0.64%)
UPP9
57,445.79
444.77
(0.78%)
NITPGI
43,120.57
349.84
(0.82%)
NBPPGI
47,456.53
417.56
(0.89%)
MZNPI
29,606.04
262.01
(0.89%)
JSMFI
44,956.50
634.55
(1.43%)
ACI
23,933.35
204.35
(0.86%)
JSGBKTI
66,537.44
474.94
(0.72%)
HBLTTI
17,692.00
04-12-2025
5.25
(0.03%)
MII30
21,983.68
201.26
(0.92%)
BF Biosciences Limited
PHARMACEUTICALS
Rs.153.99
1.59
(1.04%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Dec 5, 2025 9:19 AM
REG
DFC
CSF
ODL
Open
153.50
High
153.99
Low
153.10
Volume
51,223
CIRCUIT BREAKER
137.16 — 167.64
DAY RANGE
153.10 — 153.99
52-WEEK RANGE ^
117.00 — 253.97
Ask Price
153.50
Ask Volume
1,200
Bid Price
153.11
Bid Volume
5,990
LDCP
152.40
VAR
15.50
HAIRCUT
22.50
P/E Ratio (TTM) **
28.05
1-Year Change * ^
-36.72%
YTD Change * ^
-34.43%

No record found

Last update: Sun, Nov 30, 2025 6:06 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
153.81
Volume
0
Total Trades
0
CIRCUIT BREAKER
138.43 — 169.19
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Nov 30, 2025 6:06 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
157.84
Volume
0
Total Trades
0
CIRCUIT BREAKER
142.06 — 173.62
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Nov 30, 2025 6:06 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
156.05
Volume
0
Total Trades
0
CIRCUIT BREAKER
140.45 — 171.66
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

BF Biosciences Limited ("BFBL", "Company", or the "Issuer") was incorporated as an unlisted public limited company under the Companies Ordinance, 1984 (now Companies Act, 2017) in 2006, and operates within the pharmaceutical industry. BFBL is a 80%:20% joint venture between Ferozsons Laboratories Limited and the Bagó Group of Argentina. The Company's core operations involve the import, manufacturing, marketing and distribution of pharmaceutical products.

KEY PEOPLE
Akhter Khalid WaheedCEO
Sebastian Martin FerrarassiChairperson
Abdur RehmanCompany Secretary
ADDRESS

197-A, The Mall, Rawalpindi, Pakistan

WEBSITE

www.bfbio.com

REGISTRAR

CDC Share Registrar Services Limited, CDC House, 99-B, Block-B, S.M.C.H.S, Main Shahrah Faisal, Karachi

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Equity Profile

Market Cap (000's)
13,602,450.10
Shares
88,333,334
Free Float
26,500,000
Free Float
30.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2025Transmission of Quarterly Financial Statements for the Period Ended 30-09-2025 View   PDF
Oct 27, 2025Financial Results for the Quarter Ended 2025-09-30 View   PDF
Oct 21, 2025Annual Progress Report for the Year Ended June 30, 2025 View   PDF
Oct 3, 2025Transmission of Annual Financial Statements for the Year Ended 30-06-2025 View   PDF
Sep 23, 2025Financial Results for the Year Ended 30-06-2025 View   PDF
DateTitleDocument
Oct 27, 2025Certified true copy of the resolutions passed in the Annual General Meeting of the Company View   PDF
Oct 17, 2025Board Meeting View   
Oct 3, 2025Notice of Annual General Meeting View   PDF
Oct 2, 2025Notice of Annual General Meeting prior to publication View   PDF
Sep 15, 2025Board Meeting View   
DateTitleDocument
Nov 20, 2025Corporate Briefing Session - Presentation View   PDF
Nov 18, 2025Corporate Briefing Session View   PDF
Oct 14, 2025Material Information View   PDF
Oct 13, 2025Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Apr 17, 2025Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
20252024
Sales5,837,4663,658,720
Profit after Taxation447,147385,413
EPS5.526.09
Q1 2026Q3 2025Q2 2025Q1 2025
Sales2,432,2941,500,4691,327,2021,386,372
Profit after Taxation159,521124,52780,539115,273
EPS1.811.591.091.82
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

202520242023
Gross Profit Margin (%)39.1941.89
Net Profit Margin (%)7.6610.53
EPS Growth (%)(9.36)
PEG(3.27)

Payouts

Financial Reports